Anti-Podoplanin Antibody [LpMab-23] (A285830)

Anti-Podoplanin Antibody [LpMab-23]

Mouse monoclonal [LpMab-23] antibody to Podoplanin.

This antibody recognizes an altered glycosylation pattern that occurs on oral cancer cells and it shows minimal reactivity with the surrounding non-cancerous tissue.

WB, Flow Cytometry, IHC

Flow Cytometry: 1-5 µg/ml.

Human

Recombinant human PDPN.

Mouse

Monoclonal

LpMab-23

IgG1

kappa

Protein A chromatography.

1 mg/ml

Liquid

Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.

Aggrus, Glycoprotein 36, Glycoprotein 36 KD, gp 36, GP 38, GP 40, gp36, GP38, GP40, HT1A 1, HT1A1, hT1alpha 1, hT1alpha 2, hT1alpha1, hT1alpha2, Lung type I cell membrane associated glycoprotein, Lung type I cell membrane associated glycoprotein isoform a, Lung type I cell membrane associated glycoprotein T1A 2, OTS 8, OTS8, OTTHUMP00000009640, OTTHUMP00000044504, PA2.26, PA2.26 antigen, Pdpn, PDPN_HUMAN, Podoplanin / gp36, PSEC0003, PSEC0025, T1 alpha, T1 ALPHA GENE, T1-alpha, T1A, T1A 2, TI1A, TIA 2, TIA2